Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Johanna Zerbib,Marica Rosaria Ippolito,Yonatan Eliezer,Giuseppina De Feudis,Eli Reuveni,Anouk Savir Kadmon,Sara Martin,Sonia Viganò,Gil Leor,James Berstler,Julia Muenzner,Michael Mülleder,Emma M Campagnolo,Eldad D Shulman,Tiangen Chang,Carmela Rubolino,Kathrin Laue,Yael Cohen-Sharir,Simone Scorzoni,Silvia Taglietti,Alice Ratti,Chani Stossel,Talia Golan,Francesco Nicassio,Eytan Ruppin,Markus Ralser,Francisca Vazquez,Uri Ben-David,Stefano Santaguida
DOI: https://doi.org/10.1038/s41467-024-52176-x
2024-09-09
Abstract:Aneuploidy is a hallmark of human cancer, yet the molecular mechanisms to cope with aneuploidy-induced cellular stresses remain largely unknown. Here, we induce chromosome mis-segregation in non-transformed RPE1-hTERT cells and derive multiple stable clones with various degrees of aneuploidy. We perform a systematic genomic, transcriptomic and proteomic profiling of 6 isogenic clones, using whole-exome DNA, mRNA and miRNA sequencing, as well as proteomics. Concomitantly, we functionally interrogate their cellular vulnerabilities, using genome-wide CRISPR/Cas9 and large-scale drug screens. Aneuploid clones activate the DNA damage response and are more resistant to further DNA damage induction. Aneuploid cells also exhibit elevated RAF/MEK/ERK pathway activity and are more sensitive to clinically-relevant drugs targeting this pathway, and in particular to CRAF inhibition. Importantly, CRAF and MEK inhibition sensitize aneuploid cells to DNA damage-inducing chemotherapies and to PARP inhibitors. We validate these results in human cancer cell lines. Moreover, resistance of cancer patients to olaparib is associated with high levels of RAF/MEK/ERK signaling, specifically in highly-aneuploid tumors. Overall, our study provides a comprehensive resource for genetically-matched karyotypically-stable cells of various aneuploidy states, and reveals a therapeutically-relevant cellular dependency of aneuploid cells.